Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of SARS-CoV-2 (COVID-19) Through Pre-Exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Hydroxychloroquine in Healthcare Personnel: Randomized Clinical Trial Controlled With Placebo

NCT04334928 is registered in ClinicalTrials.gov with Plan Nacional sobre el Sida (PNS) as lead sponsor.

NCT NCT04334928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04334928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of SARS-CoV-2 (COVID-19) Through Pre-Exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Hydroxychloroquine in Healthcare Personnel: Randomized Clinical Trial Controlled With Placebo
Lead sponsor
Plan Nacional sobre el Sida (PNS)
Phase
Phase 3
Overall status
Completed
Start date
April 15, 2020
Completion date
July 11, 2021
Enrollment
1,002 (actual)
Sites
65

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection